References
1 Bozdag G, Mumusoglu S, Zengin D, Karabulut E YB. The Prevalence and Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis - PubMed. Hum Reprod. 2016;31(12)2841‐2855.
2 Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: Population based cohort study. BMJ 2011;343(7828).
3 Wang T, Fu H, Chen L, Xu Y. Pregnancy complications among women with polycystic ovary syndrome in China: A Meta-analysis. J Cent South Univ (Medical Sci 2017;42(11):1300–10.
4 Palomba S, De Wilde MA, Falbo A, Koster MPH, La Sala GB, Fauser BCJM. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 2015;21(5):575–92.
5 Taylor HS, Vanden Heuvel GB, Igarashi P. A Conserved Hox Axis in the Mouse and Human Female Reproductive System: Late Establishment and Persistent Adult Expression of the Hoxa Cluster Genes. Biol Reprod 1997;57(6):1338–45.
6 Lewis EB. A gene complex controlling segmentation in Drosophila. Nature. 1978;276(5688):565–70.
7 McGinnis W, Levine MS, Hafen E, Kuroiwa A, Gehring WJ. A conserved DNA sequence in homoeotic genes of the Drosophila Antennapedia and bithorax complexes. Nature 1984;308(5958):428–33.
8 McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell. 1992;68(2):283–302.
9 McGinnis W, Garber RL, Wirz J, Kuroiwa A, Gehring WJ. A homologous protein-coding sequence in drosophila homeotic genes and its conservation in other metazoans. Cell 1984;37(2):403–8.
10 Mullen RD, Behringer RR. Molecular genetics of Müllerian duct formation, regression and differentiation. Sex Dev 2014;8(5):281–96.
11 Krumlauf R. Hox genes in vertebrate development. Cell. 1994;78(2):191–201.
12 Block K, Kardana A, Igarashi P, Taylor HS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J 2000;14(9):1101–8.
13 Massé J, Watrin T, Laurent A, Deschamps S, Guerrier D, Pellerin I. The developing female genital tract: From genetics to epigenetics. Int. J. Dev. Biol. 2009;53(2–3):411–24.
14 Benson G V., Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: Uterine homeosis and loss of maternal Hoxa-10 expression. Development 1996;122(9):2687–96.
15 Cheng Z, Zhu Y, Su D et al. A Novel Mutation of HOXA10 in a Chinese Woman With a Mullerian Duct Anomaly - PubMed. Hum Reprod. 2011;26(11):3197-3201.
16 Filippou P HR. Is Foetal Hyperexposure to Androgens a Cause of PCOS? - PubMed. Hum Reprod Updat. 2017;23(4):421-432.
17 Piltonen TT, Giacobini P, Edvinsson Å, Hustad S, Lager S, Morin-Papunen L, et al. Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term. Fertil Steril 2019;111(3):588-596.e1.
18 Maliqueo M, Lara HE, Sánchez F, Echiburú B, Crisosto N, Sir-Petermann T. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;166(2):151–5.
19 Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 2016;7.
20 Tadaion Far F, Jahanian Sadatmahalleh S, Ziaei S, Kazemnejad A. Comparison of the umbilical cord Blood’s anti-Mullerian hormone level in the newborns of mothers with polycystic ovary syndrome (PCOS) and healthy mothers. J Ovarian Res 2019;12(1).
21 Tata B, Mimouni N, Barbotin A, Malone S, Loyens A, Pigny P, Dewailly D, Sundström-Poroma I, Piltonen T, Dal Bello F, Medana C, Prevot V, Clasadonta J, Giacobini P. Elevated prenalat anti-müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 2018; 24(6): 834-846
22 Hirobe S, He WW, Lee MM, Donahoe PK. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and sertoli cells coincides with their mitotic activity. Endocrinology 1992;131(2):854–62.
23 Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, et al. Anti-Müllerian hormone levels in serum from human foetuses and children: Pattern and clinical interest. In: Molecular and Cellular Endocrinology. Elsevier Ireland Ltd; 2003. p. 55–63.
24 Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81(2):571–6.
25 Kuiri-Hänninen T, Kallio S, Seuri R, Tyrväinen E, Liakka A, Tapanainen J, et al. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J Clin Endocrinol Metab 2011;96(11):3432–9.
26 Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. J Clin Endocrinol Metab 2010;95(11):5003–10.
27 Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N CA. The Prevalence of Congenital Uterine Anomalies in Unselected and High-Risk Populations: A Systematic Review - PubMed. Hum Reprod Updat. 2011;17(6):761-771.
28 Hart R, Sloboda DM, Doherty DA, Norman RJ, Atkinson HC, Newnham JP, et al. Circulating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of antimüllerian hormone in adolescence: A prospective cohort study. Fertil Steril 2010;94(4):1544–7.